ライフサイエンスコーパス: early diagnosis

1 HIV-1 p24 antigens in fM range, suitable for early diagnosis.

2 test (POCT) platform extremely desirable for early diagnosis.

3 ation, that occur in melanoma can aid in its early diagnosis.

4 pends on recognising disease patterns and on early diagnosis.

5 a less favourable prognosis and necessitate early diagnosis.

6 edicine and contribute to cancer therapy and early diagnosis.

7 , raise suspicion and may afford a means for early diagnosis.

8 k of vertical transmission can be reduced by early diagnosis.

9 molecular level and has a high potential on early diagnosis.

10 have relevant translational implications in early diagnosis.

11 oup at higher risk of melanoma may assist in early diagnosis.

12 opriate strategy for improving breast cancer early diagnosis.

13 risk assessment, and tailored strategies for early diagnosis.

14 stigation into PD pathogenesis and potential early diagnosis.

15 a non-invasive targeted technology for OSCC early diagnosis.

16 inclusive of mPAP >20 mm Hg, and emphasizes early diagnosis.

17 in the AN population through prevention and early diagnosis.

18 se cases, orbital MRI can be very useful for early diagnosis.

19 -consuming and take days to result, impeding early diagnosis.

20 ilarity to other inflammatory diseases makes early diagnosis a significant challenge.

21 In recent years, early diagnosis, aggressive treatment, and expanded ther

22 st cancer among women, improved capacity for early diagnosis among health workers, and the creation o

23 e, a multi-disciplinary approach provides an early diagnosis and a better clinical outcome that can o

24 Although early diagnosis and access to treatment remain crucial i

25 king, such as targeted biopsy approaches for early diagnosis and active surveillance, in addition to

26 ging appearance is essential to arrive at an early diagnosis and also to obviate biopsy in cases with

27 ound Ischemic AKI lacks a urinary marker for early diagnosis and an effective therapy.

28 Early diagnosis and antibiotics targeting this emerging

29 Early diagnosis and appropriate intervention can be life

30 of AKT3 mutations is important for providing early diagnosis and appropriate management of affected i

31 Early diagnosis and appropriate treatment can prevent un

32 hresholds could be used clinically to assist early diagnosis and appropriate treatment recommendation

33 While significant efforts in early diagnosis and better treatment are certainly neede

34 Early diagnosis and better understanding of the pathophy

35 tect a range of trace protein biomarkers for early diagnosis and can be combined with diverse pretrea

36 ophagus is easily accessible with endoscopy, early diagnosis and curative treatment of esophageal can

37 A great area of interest is early diagnosis and disease management strategies for ca

38 an aggressive vascular disease that requires early diagnosis and effective treatment.

39 tein biomarkers offers new opportunities for early diagnosis and efficient treatment of complex disea

40 Newborn screening is paramount for early diagnosis and enrolment of affected children into

41 a reliable noninvasive imaging modality for early diagnosis and follow-up of DCH over time.

42 MRI plays an important role in both the early diagnosis and follow-up of this disease.

43 the identified metabolites as biomarkers for early diagnosis and for FXTAS disease progression, respe

44 diagnosis, and may be of value for improved early diagnosis and for recruitment and monitoring of pr

45 and controversies of daunting costs, ethics, early diagnosis and health system readiness will require

46 Early diagnosis and immediate reperfusion are the most e

47 -related lung cancer in XF might have led to early diagnosis and improved OS, and increased investmen

48 Early diagnosis and initiation of antibiotic therapy wit

49 r residual disability from these attacks, so early diagnosis and initiation of attackpreventing medic

50 ortant for genetic counseling and subsequent early diagnosis and initiation of proper therapy.

51 iew, we discuss how machine learning can aid early diagnosis and interpretation of medical images as

52 patients with esophagopericardial fistulas, early diagnosis and intervention are vital.

53 r-patient technologies are needed to improve early diagnosis and intervention for patients with renal

54 e clinical features are needed to facilitate early diagnosis and intervention, especially in rural se

55 carcinoma, could generate new strategies for early diagnosis and intervention.

56 there is no known cure for Type 2 diabetes, early diagnosis and interventions are critical to preven

57 Early diagnosis and management are paramount to improve

58 Future studies are needed to confirm that early diagnosis and management can alter the disease cou

59 marker, plays a critical role in screening, early diagnosis and management of breast cancer.

60 Early diagnosis and management of CV complications in pa

61 V dysfunction and may potentially aid in the early diagnosis and management of heart failure patients

62 common congenital infections may facilitate early diagnosis and may, at times, lead to prompt initia

63 te ONOO(-) as a biomarker and target for AKI early diagnosis and medical intervention; and imply the

64 review the state-of-the-art technologies for early diagnosis and minimally invasive treatment, which

65 Biomarkers suitable for early diagnosis and monitoring disease progression are t

66 new technologies are urgently needed for the early diagnosis and monitoring of deep-seated and compli

67 ammation and remodeling can potentially help early diagnosis and monitoring of the effects of therape

68 is essentially incurable without a means of early diagnosis and no successful standard of care.

69 Early diagnosis and noninvasive detection of liver fibro

70 c imaging and late gadolinium enhancement in early diagnosis and noninvasive follow-up of ARVC patien

71 e (ColIV) for targeted nucleic acid therapy, early diagnosis and noninvasive monitoring of TAD.

72 Early diagnosis and optimal treatment of isoniazid-resis

73 hrough exhaled breath analysis, suitable for early diagnosis and population screening.

74 detecting T-cell activation would allow for early diagnosis and possibly more effective management o

75 hich demonstrated the great potential in the early diagnosis and postoperative monitoring of breast c

76 vival remains poor, and new tools to improve early diagnosis and precise treatment are needed.

77 videnced with this new device, assisting the early diagnosis and prevention of periodontal disease.

78 has been ineffective, but new approaches for early diagnosis and prevention that leverage molecular g

79 nderlying pathophysiology, possible means of early diagnosis and prevention, and whether there may be

80 ardiac biomarkers - GPBB, CK-MB and cTnT for early diagnosis and prognosis of acute myocardial infarc

81 D platform as a point-of-care device for the early diagnosis and prognosis of AMI.

82 techniques have made it possible to aid the early diagnosis and prognosis of neurodevelopmental defi

83 e lung cancer biomarkers a pressing need for early diagnosis and prognosis.

84 Early diagnosis and prompt treatment may salvage useful

85 here is increasing awareness of the need for early diagnosis and rapid specialist input from endocrin

86 entists a new precision agriculture tool for early diagnosis and real-time monitoring of plant stress

87 g biomarkers are being rapidly developed for early diagnosis and staging of disease.

88 Early diagnosis and staging of hepatic fibrosis represen

89 d to actionable metabolic tests that support early diagnosis and stratification for targeted therapeu

90 ncer diagnosis may significantly improve the early diagnosis and subsequent treatment.

91 in this Kenyan cohort, both were reduced by early diagnosis and supportive care.

92 nslatable, these markers could contribute to early diagnosis and the development of novel therapies o

93 f microRNAs are becoming crucial enablers of early diagnosis and therapeutic follow-up.

94 G-6-P-dehydrogenase activity will facilitate early diagnosis and therapeutic intervention of this nov

95 ntifying HCM patients who might benefit from early diagnosis and therapeutic interventions.

96 ients using macrophage PET holds promise for early diagnosis and therapeutic response monitoring.

97 mother and discuss the role of radiology in early diagnosis and timely management.

98 omarkers are needed for axSpA to assist with early diagnosis and to better predict treatment response

99 of intrabiliary invasion in order obtain an early diagnosis and to reduce any delay in treatment.

100 Early diagnosis and treatment can prevent or delay progr

101 Early diagnosis and treatment can reduce the severity of

102 sts and biomarkers for Kawasaki disease make early diagnosis and treatment challenging.

103 Early diagnosis and treatment is prudent in such neoplas

104 of oncologic patient care, committed to the early diagnosis and treatment of adverse cardiac events.

105 high level of clinical suspicion is key for early diagnosis and treatment of botulism.

106 Our study highlights the importance of early diagnosis and treatment of cardiac remodeling beca

107 findings suggest that better initiatives for early diagnosis and treatment of COPD are needed.

108 Heart failure management, prevention, early diagnosis and treatment of endocarditis, oral anti

109 ounger and black PLWH highlight the need for early diagnosis and treatment of HIV infection.

110 makes the receptor a promising target in the early diagnosis and treatment of several neurodegenerati

111 ge challenges faced in clinical practice for early diagnosis and treatment of several tumor samples.

112 Early diagnosis and treatment of sleep apnea in patients

113 Early diagnosis and treatment of subclinical AMR based o

114 Our study suggests that early diagnosis and treatment of subclinical AMR using D

115 nvasive biomarker of acute AMR could lead to early diagnosis and treatment of this condition and impr

116 tic experiences (PEs) is of interest because early diagnosis and treatment of those at risk of future

117 normalities, and (3) the favorable effect of early diagnosis and treatment regardless of treatment mo

118 Among survival determinants, improvements in early diagnosis and treatment were predicted to contribu

119 tomography scan can be a useful modality for early diagnosis and treatment with immunosuppressive the

120 ial to impact kidney disease risk or improve early diagnosis and treatment, and thus reduce the need

121 Early diagnosis and treatment, as well as long-term moni

122 Without early diagnosis and treatment, half of infants with HIV

123 These findings underscore the importance of early diagnosis and treatment, linkage and retention in

124 hic findings of these conditions may lead to early diagnosis and treatment, resulting in improved pat

125 ement of acute bacterial infections requires early diagnosis and treatment, which are not always easy

126 tools, such as serum biomarkers, that enable early diagnosis and treatment.

127 earch is needed to understand the effects of early diagnosis and treatment.

128 s to prevent their occurrence and facilitate early diagnosis and treatment.

129 ve inheritance pattern, who may benefit from early diagnosis and treatment.

130 ish programmes aiming for sepsis prevention, early diagnosis, and adequate treatment.

131 t appropriate strategies for the prevention, early diagnosis, and management of potential radiation i

132 Medical imaging is essential to screening, early diagnosis, and monitoring responses to cancer trea

133 ea control include strengthening prevention, early diagnosis, and treatment of patients and their par

134 or a continuous effort in cancer prevention, early diagnosis, and treatment.

135 arch Unit in Cancer Awareness, Screening and Early Diagnosis; and Cancer Research UK.

136 Early diagnosis begins with a medical history and involv

137 ncreased risk of breast cancer and of failed early diagnosis by screening mammography.

138 The lack of biomarkers for early diagnosis, clinical stratification and to monitor

139 Early diagnosis could save the child's life and vision.

140 The effects of early diagnosis, dermatologic presentation, and antifung

141 , with the aim of identifying biomarkers for early diagnosis, development, and progression of FXTAS,

142 The annual proportion of persons with early diagnosis did not increase appreciably (35% in 201

143 Clinical breast examination may improve early diagnosis directly by finding breast cancers at ea

144 n ALS-FTD may have clinical implications for early diagnosis, disease management and care planning an

145 th the purpose of identifying biomarkers for early diagnosis, disease prediction and, a progression o

146 the age spectrum our results will facilitate early diagnosis, enable counselling and anticipatory gui

147 Its early diagnosis has been remained a prime focus amongst

148 3 decades, advances in antifungal drugs and early diagnosis have improved IFD outcomes, and HSCT in

149 Early diagnosis improves melanoma survival, yet the hist

150 diagnostic processes and outcomes, tailored early diagnosis initiatives can be developed to improve

151 Early diagnosis interventions such as symptom awareness

152 These findings provide support for early diagnosis interventions targeting common cancer sy

153 reatment of AKI due to the lack of efficient early diagnosis is an important cause of its high mortal

154 man immunodeficiency virus (HIV) testing and early diagnosis is associated with effective disease man

155 This early diagnosis is becoming possible using the real-time

156 Early diagnosis is critical to ensure appropriate manage

157 Early diagnosis is critical to improve outcomes in rheum

158 53 million children worldwide and for which early diagnosis is critical to the outcome of behavior t

159 n men, preceded only by lung cancer, and its early diagnosis is crucial for a successful treatment, t

160 the rate or rhythm of the heartbeat, and an early diagnosis is essential for the timely inception of

161 c radiological signs of this entity, because early diagnosis is essential to prevent progression to l

162 Early diagnosis is important in the neurologically asymp

163 Therefore, development of new methods for early diagnosis is instantly required.

164 Early diagnosis is necessary to reduce the mortality and

165 have allowed accurate late-stage prognosis, early diagnosis is still a major challenge.

166 Early diagnosis is the key to prevent the deterioration

167 Early diagnosis is the most important determinant of ora

168 Survival could be improved by early diagnosis, new treatments, and improved case manag

169 his assay represents a major improvement for early diagnosis of A. phagocytophilum in human patients

170 Early diagnosis of acute cartilage injuries enables moni

171 t of the health status of the individual and early diagnosis of acute diseases.

172 ver patients offers a unique opportunity for early diagnosis of acute Q fever endocarditis and for th

173 n the development of point-of-care tools for early diagnosis of AD.

174 ntial to be useful clinical tools for aiding early diagnosis of AD.

175 The results may facilitate the early diagnosis of adverse drug events in clinical appli

176 y invasive and cost-effective biomarkers for early diagnosis of Alzheimer's disease (AD).

177 vides evidence that navigation tasks may aid early diagnosis of Alzheimer's disease, and the basis of

178 ma and may provide important information for early diagnosis of Alzheimer's disease.

179 C as an adjunct or alternative to cTn in the early diagnosis of AMI.

180 Early diagnosis of an infection based on antibody detect

181 ss among clinicians is imperative, promoting early diagnosis of APRT deficiency and pharmacotherapy i

182 Early diagnosis of atrial fibrillation, ideally before t

183 It is unknown whether early diagnosis of autosomal dominant polycystic kidney

184 The early diagnosis of bacteremia and initiation of treatmen

185 Early diagnosis of bacterial infections is crucial to im

186 Early diagnosis of BIA-ALCL is important as the disease

187 Early diagnosis of both syndromes provides improved trea

188 s with brain metastasis (BCBM) may allow for early diagnosis of brain metastasis and/or help for trea

189 The early diagnosis of breast cancer is crucial for the succ

190 r evolution, which may eventually facilitate early diagnosis of cancer and disease recurrence, and wh

191 region, making it a remarkable modality for early diagnosis of cancer and highly sensitive tumor sur

192 Early diagnosis of cancer is decisive for its successful

193 cleic acids (NAs) biosensors is critical for early diagnosis of cancer, genetic diseases and follows

194 Al-QS could be a suitable candidate for the early diagnosis of cancer.

195 , and potentially screen individuals for the early diagnosis of cancer.

196 ions in prostate-specific antigen can hamper early diagnosis of castration-resistant prostate cancer

197 To develop an algorithm for accurate and early diagnosis of CJD by using the RT-QuIC assay on CSF

198 cularly brain MRI, has a pivotal role in the early diagnosis of CNS complications that potentially ar

199 Early diagnosis of CRS is important for appropriate mana

200 Early diagnosis of dengue biomarkers by employing a tech

201 ings can be potentially helpful in making an early diagnosis of dengue fever.

202 early sensory activity could be utilized for early diagnosis of developmental disorders.

203 ive medical tests and found effectual in the early diagnosis of diabetes.

204 Early diagnosis of diabetic retinopathy (DR) is vital bu

205 vitro analysis of neuronal cells as well as early diagnosis of different neurological diseases relat

206 diseases, and has the potential to transform early diagnosis of disease for the benefit of patients a

207 ruction of polygenic scores (PGS) can enable early diagnosis of diseases and facilitate the developme

208 other clinical biomarkers, thus enabling the early diagnosis of diseases and the timely activation of

209 is technique hinders its applications in the early diagnosis of diseases.

210 onths after transplantation, indicating that early diagnosis of donor-derived IgE sensitization is po

211 vative point-of-care devices that enable the early diagnosis of DPN and assess the evidence for early

212 Therefore, rapid, accurate, and early diagnosis of Ebola virus disease (EVD) is critical

213 Guidelines recommend an early diagnosis of esophageal varices before incident bl

214 gests their role as potential biomarkers for early diagnosis of FXTAS.

215 Advances in prenatal screening and early diagnosis of genetic disease will potentially allo

216 te characterization of cirrhotic nodules and early diagnosis of hepatocellular carcinoma (HCC) are of

217 This timeline may allow for the early diagnosis of HGSC and STIC, followed by intent-to-

218 pplement current screening modalities to aid early diagnosis of high-risk populations and assist the

219 d assessment of histidine as a biomarker for early diagnosis of histidinemia disease in new born chil

220 sensors, microfluidics, and -omics to enable early diagnosis of HIV.

221 require a high level of suspicion to make an early diagnosis of HP before extensive pulmonary fibrosi

222 luminescence detection was developed for the early diagnosis of human cancer.

223 graft-reactive T and B cells allows for the early diagnosis of immune reactivity and therapeutic int

224 fected testicles can be a useful tool in the early diagnosis of incomplete testicular torsion.

225 ming and costly, making them inefficient for early diagnosis of infections and inconvenient for use a

226 Early diagnosis of influenza (Flu) is critical for patie

227 thy mice, indicating a potential utility for early diagnosis of intestinal tumors.

228 This technique enables the early diagnosis of intra-abdominal complications such as

229 utine baseline chest computed tomography for early diagnosis of IPA.

230 Early diagnosis of leprosy is challenging, particularly

231 Efficient diagnostic methods for early diagnosis of leptospirosis are still lacking, and

232 r biomarkers in body fluids could facilitate early diagnosis of lung cancer, so as to provide scienti

233 To identify reliable antigens for early diagnosis of MAP infection, we constructed a MAP p

234 ed active research on molecular marker-based early diagnosis of metastasis.

235 Early diagnosis of metastatic infection is crucial, beca

236 Tools to establish an early diagnosis of MNA include incorporation of MNA as a

237 nical technique for establishing an accurate early diagnosis of multiple sclerosis as well as for pre

238 In the early diagnosis of myocardial infarction (MI), beyond do

239 Early diagnosis of NAFLD is important, as this can help

240 and therapeutic options that will speed the early diagnosis of neurodegenerative diseases and their

241 great promise for detection of DA levels for early diagnosis of neurodegenerative diseases.

242 The lack of biomarkers for an early diagnosis of neurodegenerative disorders (NDs) has

243 We use the leaf-clip Raman sensor for early diagnosis of nitrogen deficiency of the model plan

244 This study provides a modality for early diagnosis of NSCLC for precision oncology that can

245 Accordingly, urinary CTXII may aid in early diagnosis of OA in symptomatic patients without ra

246 nalytes in point-of-care settings can enable early diagnosis of ocular diseases.

247 Accurate detection and early diagnosis of oral diseases such as dental caries a

248 sensor can find clinical applications in the early diagnosis of pACC and to monitor DHEAS levels in o

249 ts offer promise for automated, enhanced and early diagnosis of Parkinson's Disease.

250 mplementation might be of interest to assist early diagnosis of patients presenting with hypomorphic

251 te-specific antigen (PSA) in human serum for early diagnosis of PCa.

252 Funding of research towards early diagnosis of PDAC has decreased by 19% since 2007.

253 itoring of IRMAs with SS OCTA may facilitate early diagnosis of PDR.

254 hologic analysis, the gold standard, for the early diagnosis of primary vitreoretinal lymphoma.

255 breast cancer, MR imaging screening improves early diagnosis of prognostically relevant breast cancer

256 Early diagnosis of prostate cancer (PCa) is critical for

257 s emerged as a potentially powerful tool for early diagnosis of rheumatic heart disease (RHD).

258 a nuclease-activatable fluorescent probe for early diagnosis of SAB.

259 nal brain biomarkers, limiting the chance of early diagnosis of schizophrenia.

260 Correct and early diagnosis of sepsis leads to rapid administration

261 n of PLT-I and NEUT-Y show potential for the early diagnosis of sepsis post-burn injury.

262 w potential as biomarkers for the prediction/early diagnosis of sepsis postburn injury and neutrophil

263 Early diagnosis of T. cruzi infection is crucial.

264 d distribution could provide the means of an early diagnosis of tau-associated diseases.

265 e, sensitive, stable, and low cost to enable early diagnosis of TB in communities with scarce resourc

266 Early diagnosis of TB results in early treatment and imp

267 n in serum or plasma can be effective to the early diagnosis of the disease.

268 Early diagnosis of the highly pathogenic H5N1 avian infl

269 ighlight the role of lung ultrasonography in early diagnosis of the inflammatory phase of COVID-19.

270 ods is of high importance especially for the early diagnosis of these diseases.

271 iCCA from HCC or PSC, and could help in the early diagnosis of these diseases.

272 te and timely cognitive assessment is key to early diagnosis of this family of mental disorders.

273 s great need for noninvasive tools improving early diagnosis of this rejection type.

274 Early diagnosis of this viral disease is very important

275 investigation strategies are needed for the early diagnosis of tuberculosis (TB) disease and treatme

276 biological partners is not only crucial for early diagnosis of various diseases such as cancer and t

277 its promising clinical applications for the early diagnosis of ZIKV-associated pathologies.

278 Early diagnosis offers an opportunity for a intrauterine

279 profiles could hold clinical utility in the early diagnosis or clinical management of HIE.

280 olomics profile may help shape the future of early diagnosis or prevention efforts.

281 of tremors is disease specific, accurate and early diagnosis plays an important role in tremor manage

282 Early Diagnosis Policy Research Grant from Cancer Resear

283 have been identified as potential tools for early diagnosis, prediction of treatment response, and p

284 ggest potential strategies for advancing the early diagnosis, prevention and treatment of SCI.

285 d discovery of potential biomarkers enabling early diagnosis, prognosis and developing individualized

286 gnaling phenotypes with predictive value for early diagnosis, prognosis, or relapse and a thorough ch

287 , and to design evidence-based screening and early diagnosis programmes to address the growing burden

288 These recommendations emphasize the need for early diagnosis, prompt and timely intervention, intensi

289 lenges in UG-TB management include making an early diagnosis, raising clinical awareness, developing

290 A substantial number of patients with early diagnosis reaches adulthood and some patients are

291 Although treatment in cases of early diagnosis results in a 5-yr survival rate of nearl

292 unity-based triage programme and a practical early diagnosis scheme within existing multilevel health

293 ted at advanced stage and is in the need for early diagnosis techniques.

294 mon Broome, Dutch Lipid Clinic Network, Make Early Diagnosis to Prevent Early Deaths [MEDPED] and cho

295 r the development of functional, sustainable early diagnosis, treatment and supportive care programme

296 Increased awareness and early diagnosis using appropriate culture conditions and

297 To address the lack of early diagnosis, we report a cost-effective paper-based

298 patients with leprosy promises to strengthen early diagnosis, while preventive chemotherapy will redu

299 tial early marker of ischemic AKI that links early diagnosis with effective therapeutic interventions

300 The combination of early diagnosis with effective therapies should change t